Exela Pharma Sciences LLC is recalling approximately 103,950 vials of 8.4% Sodium Bicarbonate Injection, USP (50 mEq/50 mL). This recall was issued because the company cannot guarantee the sterility of the product, which is intended for intravenous use. If you have been treated with this medication, you should contact your healthcare provider or pharmacist immediately to discuss any concerns.
Injecting a product that is not sterile can result in serious or life-threatening systemic infections, such as sepsis or meningitis. The risk is particularly high for patients who are already hospitalized or have weakened immune systems.
Intravenous use only. Rx Only. Manufactured in Lenoir, NC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.